Skip to main content

02.04.2024 | Original Article

Impact of health practice index and cardiovascular health metrics on incident cardiovascular disease according to glucose tolerance status

verfasst von: Koshiro Murai, Kazuya Fujihara, Mayuko Harada Yamada, Yasuhiro Matsubayashi, Takaho Yamada, Midori Iwanaga, Masaru Kitazawa, Masahiko Yamamoto, Taeko Osawa, Yuta Yaguchi, Satoru Kodama, Hirohito Sone

Erschienen in: Diabetology International

Einloggen, um Zugang zu erhalten

Abstract

Aims

To evaluate and compare the association of incident cardiovascular disease (CVD) with the Health Practice Index (HPI) reflecting only lifestyle habits and Ideal Cardiovascular Health Metrics (ICVHMs) consisting of lifestyle habits and factors targeted for control in the same population according to glucose status.

Methods

This retrospective cohort study included 1,28,162 participants aged 18–72 years with no history of CVD followed for ≥ 3 years between 2008 and 2016. Participants were classified according to normal glucose tolerance (86,174), prediabetes (36,096), or diabetes (5892). HPI and ICVHMs scores were classified into three groups (high/medium/low). Multivariate Cox regression hazard analysis examined CVD risk.

Results

During a mean follow-up of 5.2 years, 1057 CVD events occurred. In prediabetes, CVD risk was significantly higher in groups with both medium and low HPI scores and ICVHMs scores compared to high scores for normal glucose tolerance (hazard ratios [HRs] for high/medium/low HPI scores were 0.95 [0.78–1.17], 1.56 [1.29–1.89], and 2.41 [1.74–3.34] and for ICVHMs scores were 0.74 [0.50–1.11], 1.58 [1.26–1.98], and 2.63 [2.10–3.31], respectively). Regarding diabetes, compared with high HPI/ICVHMs scores in the normal glucose tolerance group, a significantly increased CVD risk was observed in the high-score HPI group, but not in the high-score ICVHMs group (HPI high/medium/low HR, 1.63 [1.22–2.18], 2.19 [1.69–2.83], and 2.26 [1.34 -3.83]; ICVHMs high/medium/low HR, 1.14 [0.47–2.81], 2.38 [1.75–3.23], and 3.31 [2.50–4.38], respectively).

Conclusions

In diabetes, ideal lifestyle practices alone were insufficient for primary prevention of CVD but had a greater impact on primary prevention of CVD in prediabetes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215–22.PubMedCrossRef Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215–22.PubMedCrossRef
2.
Zurück zum Zitat Rao Kondapally Seshasai S, Kaptoge S, Thompson A, et al. Diabetes mellitus fasting glucose and risk of cause-specific death. N Engl J Med. 2011;364:829–41.PubMedPubMedCentralCrossRef Rao Kondapally Seshasai S, Kaptoge S, Thompson A, et al. Diabetes mellitus fasting glucose and risk of cause-specific death. N Engl J Med. 2011;364:829–41.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Ford ES, Zhao G, Li C. Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol. 2010;55:1310–7.PubMedCrossRef Ford ES, Zhao G, Li C. Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol. 2010;55:1310–7.PubMedCrossRef
4.
Zurück zum Zitat Cai X, Zhang Y, Li M, et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020;370:m2297.PubMedPubMedCentralCrossRef Cai X, Zhang Y, Li M, et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020;370:m2297.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Kondo T, Nakano Y, Adachi S, Murohara T. Effects of tobacco smoking on cardiovascular disease. Circ J. 2019;83:1980–5.PubMedCrossRef Kondo T, Nakano Y, Adachi S, Murohara T. Effects of tobacco smoking on cardiovascular disease. Circ J. 2019;83:1980–5.PubMedCrossRef
6.
Zurück zum Zitat Hubert HB. The importance of obesity in the development of coronary risk factors and disease: the epidemiologic evidence. Annu Rev Public Health. 1986;7:493–502.PubMedCrossRef Hubert HB. The importance of obesity in the development of coronary risk factors and disease: the epidemiologic evidence. Annu Rev Public Health. 1986;7:493–502.PubMedCrossRef
7.
Zurück zum Zitat Powell KE, Thompson PD, Caspersen CJ, Kendrick JS. Physical activity and the incidence of coronary heart disease. Annu Rev Public Health. 1987;8:253–87.PubMedCrossRef Powell KE, Thompson PD, Caspersen CJ, Kendrick JS. Physical activity and the incidence of coronary heart disease. Annu Rev Public Health. 1987;8:253–87.PubMedCrossRef
8.
Zurück zum Zitat Nanri A, Mizoue T, Shimazu T, et al. Dietary patterns and all-cause, cancer, and cardiovascular disease mortality in Japanese men and women: The Japan public health center-based prospective study. PLoS ONE. 2017;12:e0174848.PubMedPubMedCentralCrossRef Nanri A, Mizoue T, Shimazu T, et al. Dietary patterns and all-cause, cancer, and cardiovascular disease mortality in Japanese men and women: The Japan public health center-based prospective study. PLoS ONE. 2017;12:e0174848.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Wei W, Jiang W, Huang J, et al. Association of meal and snack patterns with mortality of all-cause, cardiovascular disease, and cancer: the US national health and nutrition examination survey, 2003 to 2014. J Am Heart Assoc. 2021;10:e020254.PubMedPubMedCentralCrossRef Wei W, Jiang W, Huang J, et al. Association of meal and snack patterns with mortality of all-cause, cardiovascular disease, and cancer: the US national health and nutrition examination survey, 2003 to 2014. J Am Heart Assoc. 2021;10:e020254.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Ofori-Asenso R, Owen AJ, Liew D. Skipping breakfast and the risk of cardiovascular disease and death: a systematic review of prospective cohort studies in primary prevention settings. J Cardiovasc Dev Dis. 2019;6:30.PubMedPubMedCentral Ofori-Asenso R, Owen AJ, Liew D. Skipping breakfast and the risk of cardiovascular disease and death: a systematic review of prospective cohort studies in primary prevention settings. J Cardiovasc Dev Dis. 2019;6:30.PubMedPubMedCentral
11.
Zurück zum Zitat Fan M, Sun D, Zhou T, et al. Sleep patterns, genetic susceptibility, and incident cardiovascular disease: a prospective study of 385 292 UK biobank participants. Eur Heart J. 2020;41:1182–9.PubMedCrossRef Fan M, Sun D, Zhou T, et al. Sleep patterns, genetic susceptibility, and incident cardiovascular disease: a prospective study of 385 292 UK biobank participants. Eur Heart J. 2020;41:1182–9.PubMedCrossRef
12.
Zurück zum Zitat Biddinger KJ, Emdin CA, Haas ME, et al. Association of habitual alcohol intake with risk of cardiovascular disease. JAMA Netw Open. 2022;5:e223849.PubMedPubMedCentralCrossRef Biddinger KJ, Emdin CA, Haas ME, et al. Association of habitual alcohol intake with risk of cardiovascular disease. JAMA Netw Open. 2022;5:e223849.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75:285–92.PubMedCrossRef Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75:285–92.PubMedCrossRef
14.
Zurück zum Zitat MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial. The Lancet. 2002;360:7–22 MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial. The Lancet. 2002;360:7–22
15.
Zurück zum Zitat Belloc NB, Breslow L. Relationship of physical health status and health practices. Prev Med. 1972;1:409–21.PubMedCrossRef Belloc NB, Breslow L. Relationship of physical health status and health practices. Prev Med. 1972;1:409–21.PubMedCrossRef
16.
Zurück zum Zitat Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121:586–613.PubMedCrossRef Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121:586–613.PubMedCrossRef
17.
Zurück zum Zitat Breslow L, Enstrom JE. Persistence of health habits and their relationship to mortality. Prev Med. 1980;9:469–83.PubMedCrossRef Breslow L, Enstrom JE. Persistence of health habits and their relationship to mortality. Prev Med. 1980;9:469–83.PubMedCrossRef
18.
Zurück zum Zitat Liu G, Li Y, Hu Y, et al. Influence of lifestyle on incident cardiovascular disease and mortality in patients with diabetes mellitus. J Am Coll Cardiol. 2018;71:2867–76.PubMedPubMedCentralCrossRef Liu G, Li Y, Hu Y, et al. Influence of lifestyle on incident cardiovascular disease and mortality in patients with diabetes mellitus. J Am Coll Cardiol. 2018;71:2867–76.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Long GH, Cooper AJ, Wareham NJ, Griffin SJ, Simmons RK. Healthy behavior change and cardiovascular outcomes in newly diagnosed type 2 diabetic patients: a cohort analysis of the ADDITION-Cambridge study. Diabetes Care. 2014;37:1712–20.PubMedCrossRef Long GH, Cooper AJ, Wareham NJ, Griffin SJ, Simmons RK. Healthy behavior change and cardiovascular outcomes in newly diagnosed type 2 diabetic patients: a cohort analysis of the ADDITION-Cambridge study. Diabetes Care. 2014;37:1712–20.PubMedCrossRef
20.
Zurück zum Zitat Uusitupa M, Peltonen M, Lindström J, et al. Ten-year mortality and cardiovascular morbidity in the finnish diabetes prevention study–secondary analysis of the randomized trial. PLoS ONE. 2009;4:e5656.PubMedPubMedCentralCrossRef Uusitupa M, Peltonen M, Lindström J, et al. Ten-year mortality and cardiovascular morbidity in the finnish diabetes prevention study–secondary analysis of the randomized trial. PLoS ONE. 2009;4:e5656.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing diabetes prevention study: a 20-year follow-up study. Lancet. 2008;371:1783–9.PubMedCrossRef Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing diabetes prevention study: a 20-year follow-up study. Lancet. 2008;371:1783–9.PubMedCrossRef
22.
Zurück zum Zitat Goldberg RB, Orchard TJ, Crandall JP, et al. Effects of long-term metformin and lifestyle interventions on cardiovascular events in the diabetes prevention program and its outcome study. Circulation. 2022;145:1632–41.PubMedPubMedCentralCrossRef Goldberg RB, Orchard TJ, Crandall JP, et al. Effects of long-term metformin and lifestyle interventions on cardiovascular events in the diabetes prevention program and its outcome study. Circulation. 2022;145:1632–41.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Gong Q, Zhang P, Wang J, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing diabetes prevention outcome study. Lancet Diabetes Endocrinol. 2019;7:452–61.PubMedPubMedCentralCrossRef Gong Q, Zhang P, Wang J, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing diabetes prevention outcome study. Lancet Diabetes Endocrinol. 2019;7:452–61.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Folsom AR, Yatsuya H, Nettleton JA, et al. Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol. 2011;57:1690–6.PubMedPubMedCentralCrossRef Folsom AR, Yatsuya H, Nettleton JA, et al. Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol. 2011;57:1690–6.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Wu S, An S, Li W, et al. Association of trajectory of cardiovascular health score and incident cardiovascular disease. JAMA Netw Open. 2019;2:e194758.PubMedPubMedCentralCrossRef Wu S, An S, Li W, et al. Association of trajectory of cardiovascular health score and incident cardiovascular disease. JAMA Netw Open. 2019;2:e194758.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Fang N, Jiang M, Fan Y. Ideal cardiovascular health metrics and risk of cardiovascular disease or mortality:a meta-analysis. Int J Cardiol. 2016;214:279–83.PubMedCrossRef Fang N, Jiang M, Fan Y. Ideal cardiovascular health metrics and risk of cardiovascular disease or mortality:a meta-analysis. Int J Cardiol. 2016;214:279–83.PubMedCrossRef
27.
Zurück zum Zitat Wang T, Lu J, Su Q, et al. Ideal Cardiovascular health metrics and major cardiovascular events in patients with prediabetes and diabetes. JAMA Cardiol. 2019;4:874–83.PubMedPubMedCentralCrossRef Wang T, Lu J, Su Q, et al. Ideal Cardiovascular health metrics and major cardiovascular events in patients with prediabetes and diabetes. JAMA Cardiol. 2019;4:874–83.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Kulshreshtha A, Vaccarino V, Judd SE, et al. Life’s simple 7 and risk of incident stroke. Stroke. 2013;44:1909–14.PubMedCrossRef Kulshreshtha A, Vaccarino V, Judd SE, et al. Life’s simple 7 and risk of incident stroke. Stroke. 2013;44:1909–14.PubMedCrossRef
29.
Zurück zum Zitat Lachman S, Peters RJG, Lentjes MAH, et al. Ideal cardiovascular health and risk of cardiovascular events in the EPIC-Norfolk prospective population study. Eur J Prev Cardiol. 2016;23:986–94.PubMedCrossRef Lachman S, Peters RJG, Lentjes MAH, et al. Ideal cardiovascular health and risk of cardiovascular events in the EPIC-Norfolk prospective population study. Eur J Prev Cardiol. 2016;23:986–94.PubMedCrossRef
31.
Zurück zum Zitat Fujihara K, Igarashi R, Yamamoto M, et al. Impact of glucose tolerance status on the development of coronary artery disease among working-age men. Diabetes Metab. 2017;43:261–4.PubMedCrossRef Fujihara K, Igarashi R, Yamamoto M, et al. Impact of glucose tolerance status on the development of coronary artery disease among working-age men. Diabetes Metab. 2017;43:261–4.PubMedCrossRef
32.
Zurück zum Zitat Yamada-Harada M, Fujihara K, Osawa T, et al. Relationship between number of multiple risk factors and coronary artery disease risk with and without diabetes mellitus. J Clin Endocrinol Metab. 2019;104:5084–90.PubMedCrossRef Yamada-Harada M, Fujihara K, Osawa T, et al. Relationship between number of multiple risk factors and coronary artery disease risk with and without diabetes mellitus. J Clin Endocrinol Metab. 2019;104:5084–90.PubMedCrossRef
33.
Zurück zum Zitat Gabir MM, Hanson RL, Dabelea D, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care. 2000;23:1108–12.PubMedCrossRef Gabir MM, Hanson RL, Dabelea D, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care. 2000;23:1108–12.PubMedCrossRef
34.
Zurück zum Zitat Noda M, Kato M, Takahashi Y, et al. Fasting plasma glucose and 5-year incidence of diabetes in the JPHC diabetes study - suggestion for the threshold for impaired fasting glucose among Japanese. Endocr J. 2010;57:629–37.PubMedCrossRef Noda M, Kato M, Takahashi Y, et al. Fasting plasma glucose and 5-year incidence of diabetes in the JPHC diabetes study - suggestion for the threshold for impaired fasting glucose among Japanese. Endocr J. 2010;57:629–37.PubMedCrossRef
36.
Zurück zum Zitat Kaneko H, Itoh H, Kamon T, et al. Association of cardiovascular health metrics with subsequent cardiovascular disease in young adults. J Am Coll Cardiol. 2020;76:2414–6.PubMedCrossRef Kaneko H, Itoh H, Kamon T, et al. Association of cardiovascular health metrics with subsequent cardiovascular disease in young adults. J Am Coll Cardiol. 2020;76:2414–6.PubMedCrossRef
37.
Zurück zum Zitat Fujihara K, Yamada-Harada M, Matsubayashi Y, et al. Accuracy of Japanese claims data in identifying diabetes-related complications. Pharmacoepidemiol Drug Saf. 2021;30:594–601.PubMedCrossRef Fujihara K, Yamada-Harada M, Matsubayashi Y, et al. Accuracy of Japanese claims data in identifying diabetes-related complications. Pharmacoepidemiol Drug Saf. 2021;30:594–601.PubMedCrossRef
38.
Zurück zum Zitat Tu Z-Z, Lu Q, Zhang Y-B, et al. Associations of combined healthy lifestyle factors with risks of diabetes, cardiovascular disease, cancer, and mortality among adults with prediabetes: four prospective cohort studies in china, the united kingdom, and the united states. Engineering. 2022. https://doi.org/10.1016/j.eng.2022.04.010.CrossRef Tu Z-Z, Lu Q, Zhang Y-B, et al. Associations of combined healthy lifestyle factors with risks of diabetes, cardiovascular disease, cancer, and mortality among adults with prediabetes: four prospective cohort studies in china, the united kingdom, and the united states. Engineering. 2022. https://​doi.​org/​10.​1016/​j.​eng.​2022.​04.​010.CrossRef
39.
Zurück zum Zitat Okay DM, Jackson PV, Marcinkiewicz M, Papino MN. Exercise and obesity. Prim Care Clin Off Pract. 2009;36:379–93.CrossRef Okay DM, Jackson PV, Marcinkiewicz M, Papino MN. Exercise and obesity. Prim Care Clin Off Pract. 2009;36:379–93.CrossRef
40.
Zurück zum Zitat Huang CJ, Hu HT, Fan YC, Liao YM, Tsai PS. Associations of breakfast skipping with obesity and health-related quality of life: evidence from a national survey in Taiwan. Int J Obes (Lond). 2010;34:720–5.PubMedCrossRef Huang CJ, Hu HT, Fan YC, Liao YM, Tsai PS. Associations of breakfast skipping with obesity and health-related quality of life: evidence from a national survey in Taiwan. Int J Obes (Lond). 2010;34:720–5.PubMedCrossRef
41.
Zurück zum Zitat Okada C, Imano H, Muraki I, Yamada K, Iso H. The association of having a late dinner or bedtime snack and skipping breakfast with overweight in japanese women. J Obesity. 2019;2019:2439571.CrossRef Okada C, Imano H, Muraki I, Yamada K, Iso H. The association of having a late dinner or bedtime snack and skipping breakfast with overweight in japanese women. J Obesity. 2019;2019:2439571.CrossRef
43.
Zurück zum Zitat Look ARG, Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54.CrossRef Look ARG, Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54.CrossRef
44.
Zurück zum Zitat Gregg EW, Jakicic JM, Blackburn G, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016;4:913–21.PubMedPubMedCentralCrossRef Gregg EW, Jakicic JM, Blackburn G, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016;4:913–21.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–93.PubMedCrossRef Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–93.PubMedCrossRef
46.
Zurück zum Zitat Ueki K, Sasako T, Okazaki Y, et al. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2017;5:951–64.PubMedCrossRef Ueki K, Sasako T, Okazaki Y, et al. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2017;5:951–64.PubMedCrossRef
47.
Zurück zum Zitat Sone H, Tanaka S, Tanaka S, et al. Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan diabetes complications study (JDCS). J Clin Endocrinol Metab. 2011;96:3448–56.PubMedCrossRef Sone H, Tanaka S, Tanaka S, et al. Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan diabetes complications study (JDCS). J Clin Endocrinol Metab. 2011;96:3448–56.PubMedCrossRef
48.
Zurück zum Zitat Kaneko H, Itoh H, Kiriyama H, et al. Restfulness from sleep and subsequent cardiovascular disease in the general population. Sci Rep. 2020;10:19674.PubMedPubMedCentralCrossRef Kaneko H, Itoh H, Kiriyama H, et al. Restfulness from sleep and subsequent cardiovascular disease in the general population. Sci Rep. 2020;10:19674.PubMedPubMedCentralCrossRef
Metadaten
Titel
Impact of health practice index and cardiovascular health metrics on incident cardiovascular disease according to glucose tolerance status
verfasst von
Koshiro Murai
Kazuya Fujihara
Mayuko Harada Yamada
Yasuhiro Matsubayashi
Takaho Yamada
Midori Iwanaga
Masaru Kitazawa
Masahiko Yamamoto
Taeko Osawa
Yuta Yaguchi
Satoru Kodama
Hirohito Sone
Publikationsdatum
02.04.2024
Verlag
Springer Nature Singapore
Erschienen in
Diabetology International
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-024-00708-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.